Neurothera Labs Inc. (TSXV:NTLX)

Canada · Delayed Price · Currency is CAD

0.1700

0.00 (0.00%)

Jul 17, 2026, 9:30 AM EST

13.33% (1Y)

Market Cap	14.43M +537.2%
Revenue (ttm)	1.17M -34.5%
Net Income	-5.65M
EPS	-0.08
Shares Out	84.90M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1700
Previous Close	0.1700
Day's Range	0.1700 - 0.1700
52-Week Range	0.1550 - 0.2600
Beta	-0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Neurothera Labs

Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules. The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer’s disease and agitation, autism spectrum disorder, and status epilepticus. It also focuses on e-commerce operations, which sells hemp-based products. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Newark, Delaware. Neurothera Labs Inc. is a subsidiary... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

CEO Oz Adler

Country Canada

Stock Exchange TSX Venture Exchange

Ticker Symbol NTLX

Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements